BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 25393287)

  • 1. Zinc supplementation inhibits complement activation in age-related macular degeneration.
    Smailhodzic D; van Asten F; Blom AM; Mohlin FC; den Hollander AI; van de Ven JP; van Huet RA; Groenewoud JM; Tian Y; Berendschot TT; Lechanteur YT; Fauser S; de Bruijn C; Daha MR; van der Wilt GJ; Hoyng CB; Klevering BJ
    PLoS One; 2014; 9(11):e112682. PubMed ID: 25393287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
    Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
    Rohrer B
    Adv Exp Med Biol; 2018; 1074():45-51. PubMed ID: 29721926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
    Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
    PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration.
    Saksens NT; Lechanteur YT; Verbakel SK; Groenewoud JM; Daha MR; Schick T; Fauser S; Boon CJ; Hoyng CB; den Hollander AI
    PLoS One; 2016; 11(6):e0144367. PubMed ID: 27258093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.
    Reynolds R; Hartnett ME; Atkinson JP; Giclas PC; Rosner B; Seddon JM
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5818-27. PubMed ID: 19661236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration.
    Krilis M; Qi M; Qi J; Wong JWH; Guymer R; Liew G; Hunyor AP; Madigan M; McCluskey P; Weaver J; Krilis SA; Giannakopoulos B
    Free Radic Biol Med; 2018 Dec; 129():237-246. PubMed ID: 30253188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
    Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
    JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta up-regulates complement factor B in retinal pigment epithelial cells through cytokines released from recruited macrophages/microglia: Another mechanism of complement activation in age-related macular degeneration.
    Wang J; Ohno-Matsui K; Yoshida T; Shimada N; Ichinose S; Sato T; Mochizuki M; Morita I
    J Cell Physiol; 2009 Jul; 220(1):119-28. PubMed ID: 19277984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype.
    Radu RA; Hu J; Jiang Z; Bok D
    J Biol Chem; 2014 Mar; 289(13):9113-20. PubMed ID: 24550392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Factor H-Related 3 Enhanced Inflammation and Complement Activation in Human RPE Cells.
    Schäfer N; Rasras A; Ormenisan DM; Amslinger S; Enzmann V; Jägle H; Pauly D
    Front Immunol; 2021; 12():769242. PubMed ID: 34819935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of age-related macular degeneration with complement activation products, smoking, and single nucleotide polymorphisms in South Carolinians of European and African descent.
    Rohrer B; Frazer-Abel A; Leonard A; Ratnapriya R; Ward T; Pietraszkiewicz A; O'Quinn E; Adams K; Swaroop A; Wolf BJ
    Mol Vis; 2019; 25():79-92. PubMed ID: 30820144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.
    Lorés-Motta L; Paun CC; Corominas J; Pauper M; Geerlings MJ; Altay L; Schick T; Daha MR; Fauser S; Hoyng CB; den Hollander AI; de Jong EK
    Ophthalmology; 2018 Jul; 125(7):1064-1074. PubMed ID: 29398083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CFH Y402H polymorphism is associated with elevated vitreal GM-CSF and choroidal macrophages in the postmortem human eye.
    Wang JC; Cao S; Wang A; To E; Law G; Gao J; Zhang D; Cui JZ; Matsubara JA
    Mol Vis; 2015; 21():264-72. PubMed ID: 25814824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration.
    Erie JC; Good JA; Butz JA; Pulido JS
    Am J Ophthalmol; 2009 Feb; 147(2):276-282.e1. PubMed ID: 18848316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
    Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
    Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration.
    Bhutto IA; Baba T; Merges C; Juriasinghani V; McLeod DS; Lutty GA
    Br J Ophthalmol; 2011 Sep; 95(9):1323-30. PubMed ID: 21633121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated delivery of Factor H attenuates complement C3 induced pathology in the murine retina: a potential gene therapy for age-related macular degeneration.
    Cashman SM; Gracias J; Adhi M; Kumar-Singh R
    J Gene Med; 2015; 17(10-12):229-43. PubMed ID: 26369397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic complement activation in age-related macular degeneration.
    Scholl HP; Charbel Issa P; Walier M; Janzer S; Pollok-Kopp B; Börncke F; Fritsche LG; Chong NV; Fimmers R; Wienker T; Holz FG; Weber BH; Oppermann M
    PLoS One; 2008 Jul; 3(7):e2593. PubMed ID: 18596911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.